Guangdong Kanghua Healthcare Co., Ltd. Class H (HK:3689)
:3689
Want to see HK:3689 full AI Analyst Report?
3689 Stock Chart & Stats
HK$1.72
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.72
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.91 - HK$2.30
Previous CloseN/A
Volume60.00K
Average Volume (3M)1.02K
Market Cap
HK$628.66M
Enterprise ValueHK$641.30M
Total Cash (Recent Filing)HK$743.33M
Total Debt (Recent Filing)HK$326.21M
Price to Earnings (P/E)5.5
Beta-0.03
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield9.14%
Share Statistics
EPS (TTM)0.29
Shares Outstanding84,394,000
10 Day Avg. Volume720
30 Day Avg. Volume1,020
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.34
Price to Sales (P/S)0.26
P/FCF Ratio2.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving LeverageA lower debt-to-equity (~0.22 in 2025 vs ~0.30–0.35 prior) strengthens financial flexibility and reduces refinancing risk. This durable improvement supports capital allocation for operations, investment or dividends and lowers downside risk if revenue softens over the next several quarters.
Solid Cash GenerationConsistently positive operating and free cash flow in 2025 indicate the core care-facilities operations generate cash to fund maintenance, modest growth and shareholder returns. Robust cash conversion underpins sustainability even if earnings fluctuate in the medium term.
Profitability ReboundA meaningful margin recovery to mid-single-digit EBIT and net margins in 2025 signals improved operating control and pricing or mix benefits. If maintained, these margins provide a foundation for predictable cash flow and incremental returns on incremental revenue over months to years.
Bears Say
Revenue InconsistencyUneven top-line growth—volatile across 2020–2025 with a ~3.9% decline in 2025—suggests demand sensitivity or exposure to fluctuating volumes. Persistent revenue variability complicates forecasting, limits scale benefits, and raises execution risk for long-term margin expansion.
Free Cash Flow VolatilityA ~31% decline in free cash flow despite positive absolute levels highlights cash conversion sensitivity to working capital or capex timing. This volatility can strain funding for investments or distributions in weaker quarters and increases reliance on balance-sheet flexibility.
Earnings Quality VariabilityA track record of a prior loss and pronounced year-to-year profit swings indicates earnings are not yet consistently high-quality. Such variability raises the risk that reported profits may revert, making multi-quarter planning and sustained return improvements less certain.
Guangdong Kanghua Healthcare Co., Ltd. Class H News
3689 FAQ
What was Guangdong Kanghua Healthcare Co., Ltd. Class H’s price range in the past 12 months?
Guangdong Kanghua Healthcare Co., Ltd. Class H lowest stock price was HK$0.91 and its highest was HK$2.30 in the past 12 months.
What is Guangdong Kanghua Healthcare Co., Ltd. Class H’s market cap?
Guangdong Kanghua Healthcare Co., Ltd. Class H’s market cap is HK$628.66M.
When is Guangdong Kanghua Healthcare Co., Ltd. Class H’s upcoming earnings report date?
Guangdong Kanghua Healthcare Co., Ltd. Class H’s upcoming earnings report date is Sep 01, 2026 which is in 81 days.
How were Guangdong Kanghua Healthcare Co., Ltd. Class H’s earnings last quarter?
Guangdong Kanghua Healthcare Co., Ltd. Class H released its earnings results on Mar 31, 2026. The company reported HK$0.19 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.19.
Is Guangdong Kanghua Healthcare Co., Ltd. Class H overvalued?
According to Wall Street analysts Guangdong Kanghua Healthcare Co., Ltd. Class H’s price is currently Overvalued.
Does Guangdong Kanghua Healthcare Co., Ltd. Class H pay dividends?
Guangdong Kanghua Healthcare Co., Ltd. Class H pays a Annually dividend of HK$0.206 which represents an annual dividend yield of 9.14%. See more information on Guangdong Kanghua Healthcare Co., Ltd. Class H dividends here
What is Guangdong Kanghua Healthcare Co., Ltd. Class H’s EPS estimate?
Guangdong Kanghua Healthcare Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Guangdong Kanghua Healthcare Co., Ltd. Class H have?
Guangdong Kanghua Healthcare Co., Ltd. Class H has 84,394,000 shares outstanding.
What happened to Guangdong Kanghua Healthcare Co., Ltd. Class H’s price movement after its last earnings report?
Guangdong Kanghua Healthcare Co., Ltd. Class H reported an EPS of HK$0.19 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Guangdong Kanghua Healthcare Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:3689
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Guangdong Kanghua Healthcare Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-1.06%
12-Months-Change
Fundamentals
Return on Equity
6.66%
Trailing 12-Months
Asset Growth
2.27%
Trailing 12-Months
Company Description
Guangdong Kanghua Healthcare Co., Ltd. Class H
Guangdong Kanghua Healthcare Co., Ltd. operates as an investment holding company primarily managing private hospitals throughout the People's Republic of China. The company's operations are divided into several key areas: Hospital Services, Rehabilitation and Other Healthcare Services, the Sale of Pharmaceutical Products, and Elderly Healthcare Services. It delivers a comprehensive range of medical services, including general inpatient and outpatient care, along with physical examination programs. Additionally, Kanghua Healthcare offers specialized treatments such as VIP inpatient and outpatient care, assisted reproductive services for infertile couples, and both surgical and non-surgical aesthetic procedures. These aesthetic offerings encompass advanced laser treatments for various conditions like acne, scarring, stretch marks, pigmentation, and hair removal. Beyond hospital care, the company provides rehabilitation support for individuals with physical or mental disabilities, as well as other health-related services like elder assistance and training for the disabled. It also sells pharmaceutical products and medical consumables. A substantial part of its business is dedicated to elderly care, covering assisted living, adult day programs, long-term residential care, and hospice services for older patients. The company's major facilities include Kanghua Hospital, Renkang Hospital, and Kangxin Hospital. Established in 2002, the company adopted its current name in December 2015, having previously been known as Dongguan Kanghua Enterprise Co., Ltd. It is headquartered in Dongguan, PRC, and functions as a subsidiary of Dongguan Kanghua Investment Group Co., Ltd.
Technical Analysis
EuroEyes International Eye Clinic Limited
―
Chaoju Eye Care Holdings Ltd.
―
C-MER Eye Care Holdings Limited
―
Town Health International Medical Group Ltd.
―
Arrail Group Ltd.
―